Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +2.8% | ▲ +6.1% | ▲ +5.2% | ▲ +26.8% | ▲ +45.9% | ▲ +92.6% | ▲ +86.8% | ▲ +707.0% |
| Peer average | ▲ +1.2% | ▲ +4.5% | ▲ +9.5% | ▲ +22.6% | ▲ +30.8% | ▲ +76.1% | ▲ +30.8% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-15 | 2026-09-18 | $0.28 |
| 2026-06-15 | 2026-06-18 | $0.28 |
| 2026-03-17 | 2026-03-20 | $0.28 |
| 2025-12-16 | 2025-12-19 | $0.59 |
| 2025-09-16 | 2025-09-19 | $0.31 |
| 2025-06-16 | 2025-06-20 | $0.31 |
| 2025-03-18 | 2025-03-21 | $0.29 |
| 2024-12-17 | 2024-12-20 | $0.21 |
| 2024-09-25 | 2024-09-30 | $0.36 |
| 2024-06-11 | 2024-06-17 | $0.29 |
| 2024-03-21 | 2024-03-27 | $0.28 |
| 2023-12-20 | 2023-12-27 | $0.13 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind IHE.